Skip to content

Clinical trials

Adenoma, Islet Cell trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenoma, Islet Cell Country / region: Netherlands Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20112
20171
20211
20222
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Active, not recruiting2
Completed2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Medical Center Groningen2
Exelixis1
J.M. de Laat1
Maastricht University Medical Center1
Merck Sharp & Dohme LLC1
National Cancer Institute (NCI)1
Novartis Pharmaceuticals1
RayzeBio, Inc.1
Rezolute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenoma, Islet Cell10
Neuroendocrine Tumors5
Carcinoma, Renal Cell3
Neoplasms3
Carcinoid Tumor2
Insulinoma2
Neoplasm Metastasis2
Neuroectodermal Tumors, Primitive2
Pheochromocytoma2
von Hippel-Lindau Disease2

Trials

Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.